Skip to main content
Home
Advertise with Us
News Sections
Academic Research
AI/Machine Learning
Analytics & Data Science
Clinical IT
Cybersecurity & Privacy
Editor's Picks & Featured Content
Hospital Systems & Operations
Government
Imaging
Industry Perspectives
Interoperability/HIE
Population Health Management
Q&A
Revenue Cycle Management & Finance
White Papers
Premium Articles
Achieving value-based care through the supply chain
Why Partnerships are Key to Driving Healthcare Forward
Books & Publications
Healthcare IT Conferences and Events
Contact
Menu
Home
Advertise with Us
News Sections
Academic Research
AI/Machine Learning
Analytics & Data Science
Clinical IT
Cybersecurity & Privacy
Editor's Picks & Featured Content
Hospital Systems & Operations
Government
Imaging
Industry Perspectives
Interoperability/HIE
Population Health Management
Q&A
Revenue Cycle Management & Finance
White Papers
Premium Articles
Achieving value-based care through the supply chain
Why Partnerships are Key to Driving Healthcare Forward
Books & Publications
Healthcare IT Conferences and Events
Contact
Editor’s Choice
Jeanne Cohen and Motive Medical Intelligence on Physician-Level Precision in Value-Based Care
As the healthcare industry recalibrates its ambitions for value-based care (VBC), one reality has grown increasingly difficult to ignore: aggregate data isn’t enough. Executives and clinical leaders charged with reducing costs and improving outcomes have long relied on population-level metrics and episode-based models to guide transformation. But when avoidable variation in care still accounts for hundreds of billions in waste, a shift in measurement strategy becomes essential.
Verily’s Strategic Retreat from Devices Signals Alphabet’s All-In AI Bet
Alphabet’s Verily has officially shuttered its medical device division, marking a significant realignment of the company’s once-celebrated healthcare ambitions. In doing so, Verily joins a growing list of tech-backed health ventures that are stepping away from hardware-driven innovation in favor of AI-centric strategies with faster return potential.
Photo 144193408 © Chernetskaya | Dreamstime.com
OpenAI’s Healthcare Play
OpenAI is no longer content to merely power third-party healthcare tools behind the scenes. With a deliberate shift in strategy and a growing leadership roster pulled from both Silicon Valley and digital health, the company is now building and launching its own healthcare applications. This move signals a transition from infrastructure provider to direct actor, one with intentions to shape both patient-facing and clinical decision-making platforms across care delivery.
Photo 144193408 © Chernetskaya | Dreamstime.com
Emory Lawsuit Spotlights Broader Transparency and Risk Questions in Healthcare Workforce Restructuring
A proposed class action lawsuit against Emory Healthcare over recent finance department layoffs is generating scrutiny not just for its legal claims, but for what it reveals about labor transparency, severance practices, and operational risk management in the hospital sector.
Stanford Health: Precision Drug Delivery Will Test the Boundaries of Noninvasive Therapeutics
The long-standing paradox of modern pharmacology is that the more powerful a drug becomes, the harder it is to contain. Psychiatric medications, anesthetics, and chemotherapeutics often produce life-altering effects, both therapeutic and toxic, because the body does not allow for localization. Drugs circulate systemically, binding wherever biology allows, whether needed or not.
Inner Speech BCIs Are Reframing the Future of Communication
Emerging research from Stanford Medicine marks a significant inflection point in brain-computer interface (BCI) development. Rather than simply decoding attempted movements or vocalizations, scientists have demonstrated the ability to capture and interpret inner speech, the silent, imagined articulation of words that occurs within the mind.
Anxiety Measurement Enters the Biometrics Era. But Validation Remains the Barrier.
NuraLogix’s launch of its Anura Anxiety Index signals an ambitious pivot in digital mental health: the attempt to quantify long-term anxiety through physiological signals alone.
Tech Giants Can’t Innovate Their Way Around IP Accountability
Apple’s newly redesigned blood oxygen feature is less a story of technological advancement than a case study in regulatory adaptation. After a protracted legal dispute with medical device firm Masimo, the tech giant has resumed functionality on certain Apple Watch models, this time through a modified version of the feature that attempts to sidestep ongoing intellectual property conflicts
Browser Control Is Now A Health Safety Issue
Perplexity’s surprise offer to buy Chrome reads like a tech-world stunt, yet the episode underscores a quieter reality for healthcare: whoever controls a dominant browser shapes how patients encounter clinical information, payer rules, and provider access. The first screen a consumer sees is increasingly an AI-mediated summary, not an official portal.
Solving Asset Management, Utilization, and Workflow Challenges with RTLS
One of the most persistent challenges affecting hospital efficiency is equipment loss and underutilization. Studies suggest that nurses can spend up to an hour each shift searching for medical devices, and hospitals often over-purchase by 10–20% to compensate for misplaced assets.
Hospitals Brace for AI Malpractice Megaclaims
Artificial-intelligence decision tools now shape diagnostic and administrative choices in the majority of U.S. health systems. A December 2024 survey from the Medscape & HIMSS AI Adoption by Health Systems Report found that 86 percent of responding organizations already employ at least one clinical or operational algorithm, while 72 percent list data-privacy or safety risks as a top concern.(
RUSH Bets on Membership-Based Virtual Care to Redefine Digital Access
Rush University System for Health has entered the crowded digital health market with Rush Connect+, a nationwide telehealth membership program priced at $19 per month or $189 annually. The move is both a bold consumer play and a strategic expansion of Rush’s virtual care infrastructure, one that combines concierge-style navigation with system-integrated clinical services.
Joint Commission Overhauls Standards with Outcome-Based Model
In a sweeping move to modernize hospital accreditation, The Joint Commission has launched Accreditation 360: The New Standard, a data-informed, outcomes-focused framework that significantly reshapes how healthcare organizations in the United States demonstrate safety and quality.
Algorithmic Clarity Reshapes Microlearning Strategy
Algorithmic transparency now determines the strategic value of clinical education platforms. The HTI-1 final rule obliges certified health IT to display evidence sources, data provenance, and known limitations for every predictive recommendation by 1 January 2025. In parallel, the FDA draft guidance on artificial-intelligence-enabled devices extends life-cycle duties for bias mitigation and performance monitoring across the full market-clearance process. Together, these rules shift executive attention from the speed of content production, documented in the first three articles of this series, to the verifiability of the algorithms that now shape that content for individual clinicians.(healthit.gov, fda.gov)
Microlearning Is a Critical System Asset
Across three weeks, the editorial arc of Elemeno Health’s microlearning model has shifted from concept to execution to evidence. What began as a frontline education innovation has matured into a system-level operational strategy—one that redefines how hospitals build clinical competence, sustain patient safety, and control labor costs under volatile conditions.